Gotham Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.84M Buy
55,614
+45,210
+435% +$1.91M 0.01% 1133
2025
Q4
$482K Buy
10,404
+2,219
+27% +$92.8K ﹤0.01% 1451
2025
Q3
$286K Buy
+8,185
New +$285K ﹤0.01% 1524
2025
Q1
Sell
-28,074
Closed -$804K 1569
2024
Q4
$804K Sell
28,074
-24,032
-46% -$795K 0.01% 980
2024
Q3
$2.01M Sell
52,106
-9,311
-15% -$332K 0.02% 723
2024
Q2
$1.98M Buy
61,417
+8,995
+17% +$312K 0.03% 685
2024
Q1
$2.04M Buy
52,422
+7,560
+17% +$264K 0.03% 644
2023
Q4
$1.38M Buy
44,862
+1,899
+4% +$47.6K 0.03% 702
2023
Q3
$960K Buy
42,963
+10,489
+32% +$239K 0.02% 794
2023
Q2
$698K Buy
32,474
+18,992
+141% +$431K 0.02% 873
2023
Q1
$323K Buy
+13,482
New +$358K 0.01% 1107
2021
Q3
Sell
-11,348
Closed -$268K 1043
2021
Q2
$268K Buy
+11,348
New +$262K 0.01% 876

Other funds holding COLL